Literature DB >> 17728266

Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia.

Silvana Galderisi1, Mario Quarantelli, Umberto Volpe, Armida Mucci, Giovanni Battista Cassano, Giordano Invernizzi, Alessandro Rossi, Antonio Vita, Stefano Pini, Paolo Cassano, Enrico Daneluzzo, Luca De Peri, Paolo Stratta, Arturo Brunetti, Mario Maj.   

Abstract

Negative symptoms of schizophrenia have generally been found in association with ventricular enlargement and prefrontal abnormalities. These relationships, however, have not been observed consistently, most probably because negative symptoms are heterogeneous and result from different pathophysiological mechanisms. The concept of deficit schizophrenia (DS) was introduced by Carpenter et al to identify a clinically homogeneous subgroup of patients characterized by the presence of primary and enduring negative symptoms. Findings of brain structural abnormalities reported by magnetic resonance imaging (MRI) studies focusing on DS have been mixed. The present study included 34 patients with DS, 32 with nondeficit schizophrenia (NDS), and 31 healthy comparison subjects, providing the largest set of MRI findings in DS published so far. The Schedule for the Deficit Syndrome was used to categorize patients as DS or NDS patients. The 2 patient groups were matched on age and gender and did not differ on clinical variables, except for higher scores on the negative dimension and more impaired interpersonal relationships in DS than in NDS subjects. Lateral ventricles were larger in NDS than in control subjects but were not enlarged in patients with DS. The cingulate gyri volume was smaller in NDS but not in DS patients as compared with healthy subjects. Both groups had smaller dorsolateral prefrontal cortex and temporal lobes than healthy subjects, but DS patients had significantly less right temporal lobe volume as compared with NDS patients. These findings do not support the hypothesis that DS is the extreme end of a severity continuum within schizophrenia.

Entities:  

Mesh:

Year:  2007        PMID: 17728266      PMCID: PMC2632416          DOI: 10.1093/schbul/sbm097

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  60 in total

1.  Evidence of a smaller left hippocampus and left temporal horn in both patients with first episode schizophrenia and normal control subjects.

Authors:  K Niemann; A Hammers; V A Coenen; A Thron; J Klosterkötter
Journal:  Psychiatry Res       Date:  2000-08-28       Impact factor: 3.222

2.  Grey matter correlates of syndromes in schizophrenia. A semi-automated analysis of structural magnetic resonance images.

Authors:  S E Chua; I C Wright; J B Poline; P F Liddle; R M Murray; R S Frackowiak; K J Friston; P K McGuire
Journal:  Br J Psychiatry       Date:  1997-05       Impact factor: 9.319

3.  Widespread cerebral gray matter volume deficits in schizophrenia.

Authors:  R B Zipursky; K O Lim; E V Sullivan; B W Brown; A Pfefferbaum
Journal:  Arch Gen Psychiatry       Date:  1992-03

4.  Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients.

Authors:  G Degreef; M Ashtari; B Bogerts; R M Bilder; D N Jody; J M Alvir; J A Lieberman
Journal:  Arch Gen Psychiatry       Date:  1992-07

5.  Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study.

Authors:  D H Mathalon; E V Sullivan; K O Lim; A Pfefferbaum
Journal:  Arch Gen Psychiatry       Date:  2001-02

6.  Correlation of negative symptoms in schizophrenia with frontal lobe parameters on magnetic resonance imaging.

Authors:  P Williamson; D Pelz; H Merskey; S Morrison; P Conlon
Journal:  Br J Psychiatry       Date:  1991-07       Impact factor: 9.319

7.  Double dissociation of N1 and P3 abnormalities in deficit and nondeficit schizophrenia.

Authors:  Armida Mucci; Silvana Galderisi; Brian Kirkpatrick; Paola Bucci; Umberto Volpe; Eleonora Merlotti; Fausto Centanaro; Francesco Catapano; Mario Maj
Journal:  Schizophr Res       Date:  2007-03-23       Impact factor: 4.939

8.  The deficit syndrome in the DSM-IV Field Trial. Part II. Depressive episodes and persecutory beliefs.

Authors:  B Kirkpatrick; X F Amador; S A Yale; J R Bustillo; R W Buchanan; M Tohen
Journal:  Schizophr Res       Date:  1996-05       Impact factor: 4.939

9.  Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.

Authors:  Beng-Choon Ho; Nancy C Andreasen; Peg Nopoulos; Stephan Arndt; Vincent Magnotta; Michael Flaum
Journal:  Arch Gen Psychiatry       Date:  2003-06

10.  Relationship between performance on the Stroop test and N-acetylaspartate in the medial prefrontal cortex in deficit and nondeficit schizophrenia: preliminary results.

Authors:  Pascal Delamillieure; Jean-Marc Constans; Jésus Fernandez; Perrine Brazo; Sonia Dollfus
Journal:  Psychiatry Res       Date:  2004-11-15       Impact factor: 3.222

View more
  29 in total

1.  Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan.

Authors:  Shiou-Lan Chen; Sheng-Yu Lee; Yun-Hsuan Chang; Shih-Heng Chen; Chun-Hsieh Chu; Nian-Sheng Tzeng; I-Hui Lee; Po-See Chen; Tzung Lieh Yeh; San-Yuan Huang; Yen-Kuang Yang; Ru-Band Lu; Jau-Shyong Hong
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-23       Impact factor: 4.147

Review 2.  Revisiting the diagnosis of schizophrenia: where have we been and where are we going?

Authors:  William R Keller; Bernard A Fischer; William T Carpenter
Journal:  CNS Neurosci Ther       Date:  2010-12-27       Impact factor: 5.243

3.  Gray matter volume alterations in first-episode drug-naïve patients with deficit and nondeficit schizophrenia.

Authors:  Wei Lei; Wei Deng; Mingli Li; Zongling He; Yuanyuan Han; Chaohua Huang; Xiaohong Ma; Qiang Wang; Wanjun Guo; Yinfei Li; Lijun Jiang; Qiyong Gong; Xun Hu; Nanyin Zhang; Tao Li
Journal:  Psychiatry Res       Date:  2015-09-11       Impact factor: 3.222

4.  Altered probabilistic learning and response biases in schizophrenia: behavioral evidence and neurocomputational modeling.

Authors:  James A Waltz; Michael J Frank; Thomas V Wiecki; James M Gold
Journal:  Neuropsychology       Date:  2011-01       Impact factor: 3.295

5.  Differences in glucose tolerance between deficit and nondeficit schizophrenia.

Authors:  Brian Kirkpatrick; Emilio Fernandez-Egea; Clemente Garcia-Rizo; Miguel Bernardo
Journal:  Schizophr Res       Date:  2008-11-28       Impact factor: 4.939

6.  The error-related negativity (ERN) and psychopathology: toward an endophenotype.

Authors:  Doreen M Olvet; Greg Hajcak
Journal:  Clin Psychol Rev       Date:  2008-07-09

7.  Mapping Convergent and Divergent Cortical Thinning Patterns in Patients With Deficit and Nondeficit Schizophrenia.

Authors:  Teng Xie; Xiangrong Zhang; Xiaowei Tang; Hongying Zhang; Miao Yu; Gaolang Gong; Xiang Wang; Alan Evans; Zhijun Zhang; Yong He
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

8.  Multivariate Associations Among Behavioral, Clinical, and Multimodal Imaging Phenotypes in Patients With Psychosis.

Authors:  Dominik A Moser; Gaelle E Doucet; Won Hee Lee; Alexander Rasgon; Hannah Krinsky; Evan Leibu; Alex Ing; Gunter Schumann; Natalie Rasgon; Sophia Frangou
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 21.596

9.  The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia.

Authors:  Shiou-Lan Chen; Sheng-Yu Lee; Yun-Hsuan Chang; Shih-Heng Chen; Chun-Hsien Chu; Tzu-Yun Wang; Po-See Chen; I-Hui Lee; Yen-Kuang Yang; Jau-Shyong Hong; Ru-Band Lu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-01-25       Impact factor: 5.067

10.  White matter alterations in deficit schizophrenia.

Authors:  Laura M Rowland; Elena A Spieker; Alan Francis; Peter B Barker; William T Carpenter; Robert W Buchanan
Journal:  Neuropsychopharmacology       Date:  2008-12-03       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.